2024 Cell and Gene: Research Review

Table of Contents

Chapter 1 Foreword

• Research Review Scope

Chapter 2 Cell and Gene Therapy Tools, and Reagents: Global Markets (BIO208C)

• Scope of Report of Cell and Gene Therapy Tools, and Reagents
• Market Summary of Cell and Gene Therapy Tools, and Reagents
• Market Overview of Cell and Gene Therapy Tools, and Reagents
• Approved CGT Products
• Market Dynamics of Cell and Gene Therapy Tools, and Reagents
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Segmentation Analysis of Cell and Gene Therapy Tools, and Reagents
• Segmentation Breakdown of Cell and Gene Therapy Tools, and Reagents
• Global Market for CGT Tools and Reagents, by Product
• Immunoassays
• Bioreactors
• Leukapheresis
• GMP Antibodies
• Multiplex Immunoassays
• Vectors
• Cell Separation
• Cryopreservation
• Cell Expansion
• Media
• GMP Proteins
• GMP Small Molecules
• CRS Monitoring
• Global Market for CGT Tools and Reagents, by Application
• Cancer
• Rare Diseases
• Other Diseases
• Global Market for CGT Tools and Reagents, by End User
• Pharmaceutical and Biotech Companies
• Academic and Research Institutes
• Clinical Laboratories
• Geographic Breakdown
• Global Market for CGT Tools and Reagents, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Emerging Technologies and Developments of Cell and Gene Therapy Tools, and Reagents
• Closed and Automated Systems
• Single-Use Technologies
• Sustainability in the CGT Tool and Reagent Market: ESG Perspective
• Introduction to ESG
• ESG Performance in the Industry
• ESG Practices in the CGT Tool and Reagent Industry
• Environmental Performance
• Social Performance
• Governance Performance
• Concluding Remarks from BCC Research

Chapter 3 Cell Therapy Biomanufacturing: Global Markets (BIO211B)

• Scope of Report of Cell Therapy Biomanufacturing
• Market Summary of Cell Therapy Biomanufacturing
• Market Overview of Cell Therapy Biomanufacturing
• Overview
• Market Dynamics of Cell Therapy Biomanufacturing
• Overview
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Segmentation Analysis of Cell Therapy Biomanufacturing
• Key Market Trends
• Cell Therapy Biomanufacturing: Global Markets
• Segmentation Breakdown of Cell Therapy Biomanufacturing
• Market Analysis of Cell Therapy Biomanufacturing, by Product Type
• Market Analysis of Cell Therapy Biomanufacturing, by Application
• Skeletal Muscle Repair
• Bone Repair
• Cancer
• Cardiovascular Diseases
• Neurological Disorders
• Other Diseases
• Geographic Breakdown of Cell Therapy Biomanufacturing
• Market Analysis of Cell Therapy Biomanufacturing, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 4 Gene Synthesis: Technologies and Global Markets (BIO251A)

• Scope of Report of Gene Synthesis
• Market Summary of Gene Synthesis
• Market Overview of Gene Synthesis
• Overview of Gene Synthesis
• Market Dynamics of Gene Synthesis
• Overview
• Market Drivers
• Restraints
• Opportunities
• Challenges
• Segmentation Breakdown of Gene Synthesis
• Gene Synthesis: Global Market
• Global Market for Gene Synthesis, by Method
• Solid-phase Synthesis
• PCR-based Enzyme Synthesis
• Chip-based Synthesis
• Global Market for Gene Synthesis, by Services
• Antibody DNA Synthesis
• Viral DNA Synthesis
• Other Gene Synthesis Services
• Gene Synthesis: Global Markets, by Application
• Gene and Cell Therapy Development
• Vaccine Development
• Disease Diagnosis
• Other Applications
• Global Market for Gene Synthesis, by End User
• Academic and Government Research Institutes
• Biotechnology and Pharmaceutical Companies
• Contract Research Organizations
• Geographic Breakdown of Gene Synthesis
• In-house or Outsource?
• Cost Considerations
• Quality Control and Assurance
• Convenience and Turnaround Time
• Customization and Specialization
• Strategic Considerations
• M&A and Venture Funding of Gene Synthesis
• In Summation

Chapter 5 Global Automated and Closed Cell Therapy Market (BIO258A)

• Scope of Report of Automated and Closed Cell Therapy
• Market Insights of Automated and Closed Cell Therapy
• Market Overview of Automated and Closed Cell Therapy
• Overview
• Market Dynamics of Automated and Closed Cell Therapy
• Market Drivers
• Market Restraints
• Market Opportunities
• Segmentation Breakdown of Automated and Closed Cell Therapy
• Global Automated and Closed Cell Therapy Market by Automation Type
• Semi-Automated Cell Therapy
• Fully Automated Cell Therapy
• Global Automated and Closed Cell Therapy Market by Cell Type
• CAR-T Cells
• Stem Cells
• Other Cell Types
• Global Automated and Closed Cell Therapy Market by Application
• Market Size and Forecast
• Clinical
• Commercial
• Geographic Breakdown of Automated and Closed Cell Therapy
• Global Market for Automated and Closed Cell Therapy by Region
• Market Size and Forecast
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

Chapter 6 Global Market for Cell and Gene Therapy (BIO225B)

• Scope of Report of Cell and Gene Therapy
• Market Summary of Cell and Gene Therapy
• Market Value of Cell and Gene Therapy
• Market Overview of Cell and Gene Therapy
• Cell and Gene Therapy Overview
• Market Dynamics of Cell and Gene Therapy
• Market Drivers
• Market Restraints
• Market Opportunities
• Segmentation Breakdown of Cell and Gene Therapy
• Global Market for Cell and Gene Therapy
• Market Analysis
• Cell Therapy
• Market Size and Forecast
• Gene-modified Cell Therapy
• Market Size and Forecast
• Gene Therapy
• Market Forecast
• Vectors Used in Gene-modified Cell Therapy and Gene Therapy
• Market Analysis
• Adeno-Associated Viral Vectors
• Retroviral Vectors
• Lentiviral Vectors
• Other Vectors Used in Gene Therapy
• Market Breakdown by Drug Product
• Zolgensma
• Yescarta
• Kymriah
• Abecma
• Maci
• Tecartus
• Epicel
• Other Drug Products
• Market Breakdown by Application
• Oncology
• Rare Diseases
• Ophthalmology
• Other Therapeutic Areas
• Geographic Breakdown of Cell and Gene Therapy
• Market Breakdown of Cell and Gene Therapy by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 7 Global Live Cell Imaging Market (BIO256A)

• Scope of Report of Live Cell Imaging
• Market Summary of Live Cell Imaging
• Market Overview of Live Cell Imaging
• Overview
• Market Dynamics of Live Cell Imaging
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Challenges
• Segmentation Breakdown of Live Cell Imaging
• Market Segmentation of Live Cell Imaging by Components
• Instruments and Software
• Consumables
• Services
• Market Segmentation of Live Cell Imaging, by Technology
• Time-Lapse Microscopy
• Fluorescence Resonance Energy Transfer (FRET)
• Fluorescence Recovery After Photobleaching (FRAP)
• High-Content Screening (HCS)
• Other Technologies
• Market Segmentation of Live Cell Imaging by End User
• Pharmaceutical and Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations
• Geographic Breakdown of Live Cell Imaging
• North America
• Europe
• Asia-Pacific
• Rest of World

Chapter 8 Global Single-cell Technologies Market (BIO257A)

• Scope of Report of Single-cell Technologies
• Market Summary of Single-cell Technologies
• Market Overview of Single-cell Technologies
• Market Dynamics of Single-cell Technologies
• Market Drivers
• Market Restraints
• Market Opportunities
• Market Challenges
• Segmentation Breakdown of Single-cell Technologies
• Market Analysis of Single-cell Technologies by Product
• Consumables
• Instruments
• Market Breakdown of Single-cell Technologies by Cell Type
• Human Cells
• Animal Cells
• Microbial Cells
• Market Breakdown by Technique
• Flow Cytometry
• Next-Generation Sequencing
• Polymerase Chain Reaction
• Microscopy
• Mass Spectrometry
• Other Techniques
• Market Breakdown of Single-cell Technologies by Application
• Research Applications
• Medical Applications
• Market Breakdown of Single-cell Technologies by End User
• Research and Academic Laboratories
• Biotechnology and Pharmaceutical Companies
• Hospitals and Diagnostic Laboratories
• Cell Banks and IVF Centers
• Geographic Breakdown of Single-cell Technologies
• Market Analysis by Region of Single-cell Technologies
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 9 Appendix

• Methodology
• Analyst's Credentials

List of Tables

• Table 1 : Global Market for CGT Tools and Reagents, by Application, Through 2029
• Table 2 : Global Market for CGT Tools and Reagents, by Region, Through 2029
• Table 3 : Approved CGT Products, as of 2024
• Table 4 : Global Cancer Statistics, 2022
• Table 5 : Global Market for CGT Tools and Reagents, by Product, Through 2029
• Table 6 : Global Market for CGT Tools and Reagents for Immunoassays, by Region, Through 2029
• Table 7 : Global Market for CGT Tools and Reagents for Bioreactors, by Region, Through 2029
• Table 8 : Global Market for CGT Tools and Reagents for Leukapheresis, by Region, Through 2029
• Table 9 : Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, Through 2029
• Table 10 : Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, Through 2029
• Table 11 : Global Market for CGT Tools and Reagents for Vectors, by Region, Through 2029
• Table 12 : Global Market for CGT Tools and Reagents for Cell Separation, by Region, Through 2029
• Table 13 : Global Market for CGT Tools and Reagents for Cryopreservation, by Region, Through 2029
• Table 14 : Global Market for CGT Tools and Reagents for Cell Expansion, by Region, Through 2029
• Table 15 : Global Market for CGT Tools and Reagents for Media, by Region, Through 2029
• Table 16 : Global Market for CGT Tools and Reagents for GMP Proteins, by Region, Through 2029
• Table 17 : Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, Through 2029
• Table 18 : Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, Through 2029
• Table 19 : Global Market for CGT Tools and Reagents, by Application, Through 2029
• Table 20 : Global Market for CGT Tools and Reagents for Cancer, by Region, Through 2029
• Table 21 : Global Market for CGT Tools and Reagents for Rare Diseases, by Region, Through 2029
• Table 22 : Global Market for CGT Tools and Reagents for Other Diseases, by Region, Through 2029
• Table 23 : Global Market for CGT Tools and Reagents, by End User, Through 2029
• Table 24 : Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, Through 2029
• Table 25 : Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, Through 2029
• Table 26 : Global Market for CGT Tools and Reagents for Clinical Labs, by Region, Through 2029
• Table 27 : Global Market for CGT Tools and Reagents, by Region, Through 2029
• Table 28 : North American Market for CGT Tools and Reagents, by Product, Through 2029
• Table 29 : North American Market for CGT Tools and Reagents, by Application, Through 2029
• Table 30 : North American Market for CGT Tools and Reagents, by End User, Through 2029
• Table 31 : European Research Initiatives Focused on Personalized Medicine
• Table 32 : European Market for CGT Tools and Reagents, by Product, Through 2029
• Table 33 : European Market for CGT Tools and Reagents, by Application, Through 2029
• Table 34 : European Market for CGT Tools and Reagents, by End User, Through 2029
• Table 35 : Asia-Pacific Market for CGT Tools and Reagents, by Product, Through 2029
• Table 36 : Asia-Pacific Market for CGT Tools and Reagents, by Application, Through 2029
• Table 37 : Asia-Pacific Market for CGT Tools and Reagents, by End User, Through 2029
• Table 38 : RoW Market for CGT Tools and Reagents, by Product, Through 2029
• Table 39 : RoW Market for CGT Tools and Reagents, by Application, Through 2029
• Table 40 : RoW Market for CGT Tools and Reagents, by End User, Through 2029
• Table 41 : Focus Areas in ESG Metrics
• Table 42 : Environmental Performance Initiatives in the CGT Tool and Reagent Market
• Table 43 : Social Performance Initiatives in the CGT Tool and Reagent Market
• Table 44 : Governance Performance Initiatives in the CGT Tool and Reagent Market
• Table 45 : ESG Rankings for Leaders in the Market for CGT Tools and Reagents, 2024*
• Table 46 : Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2029
• Table 47 : Global Market for Cell Therapy Biomanufacturing, by Application, Through 2029
• Table 48 : Global Market for Cell Therapy Biomanufacturing, Through 2029
• Table 49 : Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2029
• Table 50 : Global Market for Cell Therapy Biomanufacturing, by Application, Through 2029
• Table 51 : Global Market for Cell Therapy Biomanufacturing, by Region, Through 2029
• Table 52 : North American Market for Cell Therapy Biomanufacturing, by Country, Through 2029
• Table 53 : European Market for Cell Therapy Biomanufacturing, by Country, Through 2029
• Table 54 : Asia-Pacific Market for Cell Therapy Biomanufacturing, by Country, Through 2029
• Table 55 : Global Market for Gene Synthesis, Through 2028
• Table 56 : Global Market for Gene Synthesis, by Services, Through 2028
• Table 57 : Global Market for Gene Synthesis, Through 2028
• Table 58 : Global Market for Gene Synthesis, by Method, Through 2028
• Table 59 : Global Market for Solid-phase Synthesis, by Region, Through 2028
• Table 60 : Global Market for PCR-based Enzyme Synthesis, by Region, Through 2028
• Table 61 : Global Market for Chip-based Synthesis, by Region, Through 2028
• Table 62 : Global Market for Gene Synthesis, by Services, Through 2028
• Table 63 : Global Market for Antibody DNA Synthesis, by Region, Through 2028
• Table 64 : Global Market for Viral DNA Synthesis, by Region, Through 2028
• Table 65 : Global Market for Other Synthesis Services, by Region, Through 2028
• Table 66 : Global Market for Gene Synthesis, by Application, Through 2028
• Table 67 : Global Market for Gene and Cell Therapy Development Applications, by Region, Through 2028
• Table 68 : Global Market for Vaccine Development Applications, by Region, Through 2028
• Table 69 : Global Market for Disease Diagnosis Applications, by Region, Through 2028
• Table 70 : Global Market for Other Applications, by Region, Through 2028
• Table 71 : Global Market for Gene Synthesis, by End User, Through 2028
• Table 72 : Global Market for Gene Synthesis Used by Academic and Government Research Institutes, by Region, Through 2028
• Table 73 : Global Market for Gene Synthesis Used by Biotechnology and Pharmaceutical Companies, by Region, Through 2028
• Table 74 : Global Market for Gene Synthesis Used by Contract Research Organizations, by Region, Through 2028
• Table 75 : Mergers and Acquisitions (M&A), 2021-2023
• Table 76 : Venture Funding, 2022 and 2023
• Table 77 : Global Market for Automated and Closed Cell Therapy, by Region, Through 2029
• Table 78 : Differences between Semi-Automation and Full Automation in Cell Therapy
• Table 79 : Global Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
• Table 80 : Select Semi-Automated Cell Therapy Systems
• Table 81 : Global Market for Semi-Automated Cell Therapy, by Region, Through 2029
• Table 82 : Global Market for Semi-Automated Cell Therapy, by Workflow, Through 2029
• Table 83 : Global Market for Automated and Closed Apheresis, by Region, Through 2029
• Table 84 : Global Market for Automated and Closed Expansion, by Region, Through 2029
• Table 85 : Global Market for Automated and Closed Fill-Finish, by Region, Through 2029
• Table 86 : Global Market for Automated and Closed Separation, by Region, Through 2029
• Table 87 : Global Market for Other Automated and Closed Workflows, by Region, Through 2029
• Table 88 : Global Market for Fully Automated Cell Therapy, by Region, Through 2029
• Table 89 : Global Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
• Table 90 : FDA-Approved CAR-T Cell Therapies
• Table 91 : Global Market for Automated and Closed CAR-T Cell Therapy, by Region, Through 2029
• Table 92 : Global Market for Automated and Closed Stem Cell Therapy, by Region, Through 2029
• Table 93 : Global Market for Automated and Closed Other Cell Therapies, by Region, Through 2029
• Table 94 : Global Market for Automated and Closed Cell Therapy, by Application, Through 2029
• Table 95 : Global Market for Clinical Automated and Closed Cell Therapy, by Region, Through 2029
• Table 96 : Global Market for Commercial Automated and Closed Cell Therapy, by Region, Through 2029
• Table 97 : Global Market for Automated and Closed Cell Therapy, by Region, Through 2029
• Table 98 : North American Market for Automated and Closed Cell Therapy, by Country, Through 2029
• Table 99 : North American Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
• Table 100 : North American Market for Semi-automated Automated and Closed Cell Therapy, by Workflow, Through 2029
• Table 101 : North American Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
• Table 102 : North American Market for Automated and Closed Cell Therapy, by Application, Through 2029
• Table 103 : European Market for Automated and Closed Cell Therapy, by Country, Through 2029
• Table 104 : European Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
• Table 105 : European Market for Semi-Automated Automated and Closed Cell Therapy, by Workflow, Through 2029
• Table 106 : European Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
• Table 107 : European Market for Automated and Closed Cell Therapy, by Application, Through 2029
• Table 108 : Asia-Pacific Market for Automated and Closed Cell Therapy, by Country, Through 2029
• Table 109 : Asia-Pacific Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
• Table 110 : Asia-Pacific Market for Semi-Automated and Closed Cell Therapy, by Workflow, Through 2029
• Table 111 : Asia-Pacific Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
• Table 112 : Asia-Pacific Market for Automated and Closed Cell Therapy, by Application, Through 2029
• Table 113 : RoW Market for Automated and Closed Cell Therapy, by Automation Type, Through 2029
• Table 114 : RoW Market for Semi-Automated and Closed Cell Therapy, by Workflow, Through 2029
• Table 115 : RoW Market for Automated and Closed Cell Therapy, by Cell Type, Through 2029
• Table 116 : RoW Market for Automated and Closed Cell Therapy, by Application, Through 2029
• Table 117 : Global Market for Cell and Gene Therapy, by Type of Therapy, Through 2028
• Table 118 : Number of New Cases and Deaths Due to Various Cancers Globally, 2020
• Table 119 : Comparison of Accelerated Approvals for Various Drugs
• Table 120 : Global Market for Cell and Gene Therapy, by Type of Therapy, Through 2028
• Table 121 : Global Market for Cell Therapy, by Region, Through 2028
• Table 122 : Approved CAR-T Products, as of December 2023
• Table 123 : Global Market for Gene-modified Cell Therapy, by Region, Through 2028
• Table 124 : Global Market for Gene Therapy, by Region, Through 2028
• Table 125 : Global Market for Gene-modified Cell Therapy and Gene Therapy, by Vector Type, Through 2028
• Table 126 : Global Market for Cell and Gene Therapy, by Drug Product, Through 2028
• Table 127 : Global Market for Cell and Gene Therapy, by Application, Through 2028
• Table 128 : Global Market for Cell and Gene Therapy for Oncology, by Region, Through 2028
• Table 129 : Global Market for Cell and Gene Therapy for Rare Diseases, by Region, Through 2028
• Table 130 : Global Market for Cell and Gene Therapy for Ophthalmology, by Region, Through 2028
• Table 131 : Global Market for Cell and Gene Therapy for Other Therapeutic Areas, by Region, Through 2028
• Table 132 : Global Market for Cell and Gene Therapy, by Region, Through 2028
• Table 133 : North American Market for Cell and Gene Therapy, by Country, Through 2028
• Table 134 : European Market for Cell and Gene Therapy, by Country, Through 2028
• Table 135 : Asia-Pacific Market for Cell and Gene Therapy, by Country, Through 2028
• Table 136 : Global Market for Live Cell Imaging, by Region, Through 2029
• Table 137 : Global Market for Live Cell Imaging, by Components, Through 2029
• Table 138 : Global Market for Live Cell Imaging Instruments and Software, by Region, Through 2029
• Table 139 : Global Market for Live Cell Imaging Consumables, by Region, Through 2029
• Table 140 : Global Market for Live Cell Imaging Services, by Region, Through 2029
• Table 141 : Global Market for Live Cell Imaging, by Technology, Through 2029
• Table 142 : Global Market for Time-Lapse Microscopy, by Region, Through 2029
• Table 143 : Global Market for Fluorescence Resonance Energy Transfer, by Region, Through 2029
• Table 144 : Global Market for Fluorescence Recovery After Photobleaching, by Region, Through 2029
• Table 145 : Global Market for High-Content Screening, by Region, Through 2029
• Table 146 : Global Market for Other Technologies in Live Cell Imaging, by Region, Through 2029
• Table 147 : Global Market for Live Cell Imaging, by End User, Through 2029
• Table 148 : Global Market for Pharmaceutical and Biotechnology Companies Using Live Cell Imaging, by Region, Through 2029
• Table 149 : A Few Academic Research Institute Using Live Cell Imaging Research
• Table 150 : Global Market for Academic Research Institutes Using Live Cell Imaging, by Region, Through 2029
• Table 151 : A Few Contract Research Organizations Using Live Cell Imaging
• Table 152 : Global Market for Contract Research Organizations Using Live Cell Imaging, by Region, Through 2029
• Table 153 : Global Market for Live Cell Imaging, by Region, Through 2029
• Table 154 : North American Market for Live Cell Imaging, by Country, Through 2029
• Table 155 : North American Market for Live Cell Imaging, by Components, Through 2029
• Table 156 : North American Market for Live Cell Imaging, by Technology, Through 2029
• Table 157 : North American Market for Live Cell Imaging, by End User, Through 2029
• Table 158 : U.S. Market for Live Cell Imaging, Through 2029
• Table 159 : Canadian Market for Live Cell Imaging, Through 2029
• Table 160 : Mexican Market for Live Cell Imaging, Through 2029
• Table 161 : European Market for Live Cell Imaging, by Country, Through 2029
• Table 162 : European Market for Live Cell Imaging, by Components, Through 2029
• Table 163 : European Market for Live Cell Imaging, by Technology, Through 2029
• Table 164 : European Market for Live Cell Imaging, by End User, Through 2029
• Table 165 : German Market for Live Cell Imaging, Through 2029
• Table 166 : U.K. Market for Live Cell Imaging, Through 2029
• Table 167 : French Market for Live Cell Imaging, Through 2029
• Table 168 : Spanish Market for Live Cell Imaging, Through 2029
• Table 169 : Italian Market for Live Cell Imaging, Through 2029
• Table 170 : Rest of European Market for Live Cell Imaging, Through 2029
• Table 171 : Asia-Pacific Market for Live Cell Imaging, by Country, Through 2029
• Table 172 : Asia-Pacific Market for Live Cell Imaging, by Components, Through 2029
• Table 173 : Asia-Pacific Market for Live Cell Imaging, by Technology, Through 2029
• Table 174 : Asia-Pacific Market for Live Cell Imaging, by End User, Through 2029
• Table 175 : Chinese Market for Live Cell Imaging, Through 2029
• Table 176 : Japanese Market for Live Cell Imaging, Through 2029
• Table 177 : Indian Market for Live Cell Imaging, Through 2029
• Table 178 : South Korean Market for Live Cell Imaging, Through 2029
• Table 179 : Rest of Asia-Pacific Market for Live Cell Imaging, Through 2029
• Table 180 : Rest of the World Market for Live Cell Imaging, by Components, Through 2029
• Table 181 : Rest of the World Market for Live Cell Imaging, by Technology, Through 2029
• Table 182 : Rest of the World Market for Live Cell Imaging, by End User, Through 2029
• Table 183 : Global Market for Single-Cell Technologies, by Product, Through 2029
• Table 184 : Assay Kits Offered by 10X Genomics
• Table 185 : Global Market for Single-Cell Technologies Consumables, by Region, Through 2029
• Table 186 : Single-Cell Technologies Flow Cytometry Systems, by Company
• Table 187 : Single-Cell Technologies NGS Systems, by Company
• Table 188 : Single-Cell Technologies PCR Systems, by Company
• Table 189 : Single-Cell Technologies Mass Spectrophotometers, by Company
• Table 190 : Single-Cell Technologies Microscopes, by Company
• Table 191 : Global Market for Single-Cell Technologies Instruments, by Region, Through 2029
• Table 192 : Global Market for Single-Cell Technologies, by Cell Type, Through 2029
• Table 193 : Global Market for Single-Cell Technologies in the Human Cells Segment, by Region, Through 2029
• Table 194 : Global Market for Single-Cell Technologies in the Animal Cells Segment, by Region, Through 2029
• Table 195 : Global Market for Single-Cell Technologies in the Microbial Cells Segment, by Region, Through 2029
• Table 196 : Global Market for Single-Cell Technologies, by Technique, Through 2029
• Table 197 : Global Market for Flow Cytometry in Single-Cell Technologies, by Region, Through 2029
• Table 198 : Global Market for Next-Generation Sequencing in Single-Cell Technologies, by Region, Through 2029
• Table 199 : Global Market for Polymerase Chain Reaction in Single-Cell Technologies, by Region, Through 2029
• Table 200 : Global Market for Microscopy in Single-Cell Technologies, by Region, Through 2029
• Table 201 : Global Market for Mass Spectrometry in Single-Cell Technologies, by Region, Through 2029
• Table 202 : Global Market for Other Techniques in Single-Cell Technologies, by Region, Through 2029
• Table 203 : Global Market for Single-Cell Technologies, by Application, Through 2029
• Table 204 : Global Market for Research Applications in Single-Cell Technologies, by Region, Through 2029
• Table 205 : Global Market for Medical Applications of Single-Cell Technologies, by Region, Through 2029
• Table 206 : Global Market for Single-Cell Technologies, by End User, Through 2029
• Table 207 : Global Market for Single-Cell Technologies in Research and Academic Laboratories, by Region, Through 2029
• Table 208 : Global Market for Single-Cell Technologies in Biotechnology and Pharmaceutical Companies, by Region, Through 2029
• Table 209 : Global Market for Single-Cell Technologies in Hospitals and Diagnostic Laboratories, by Region, Through 2029
• Table 210 : Stem Cell Banks and Registries Worldwide, by Country
• Table 211 : Global Market for Single-Cell Technologies in Cell Banks and IVF Centers, by Region, Through 2029
• Table 212 : Global Market for Single-Cell Technologies, by Region, Through 2029

List of Figures

• Figure 1 : Global Market for CGT Tools and Reagents, by Application, 2021-2029
• Figure 2 : Global Market for CGT Tools and Reagents, by Region, 2021-2029
• Figure 3 : Market Dynamics of CGT Tools and Reagents
• Figure 4 : CGT Sector Investments, 2018-2023
• Figure 5 : CGT Sector Investments, by Deal Type, Q1 2024
• Figure 6 : Global Market Shares of CGT Tools and Reagents, by Product, 2024
• Figure 7 : Global Market for CGT Tools and Reagents for Immunoassays, by Region, 2021-2029
• Figure 8 : Global Market for CGT Tools and Reagents for Bioreactors, by Region, 2021-2029
• Figure 9 : Global Market for CGT Tools and Reagents for Leukapheresis, by Region, 2021-2029
• Figure 10 : Global Market for CGT Tools and Reagents for GMP Antibodies, by Region, 2021-2029
• Figure 11 : Global Market for CGT Tools and Reagents for Multiplex Immunoassays, by Region, 2021-2029
• Figure 12 : Global Market Shares of Gene Therapy Clinical Trials, by Vector Type, 2022
• Figure 13 : Global Market for CGT Tools and Reagents for Vectors, by Region, 2021-2029
• Figure 14 : Global Market for CGT Tools and Reagents for Cell Separation, by Region, 2021-2029
• Figure 15 : Global Market for CGT Tools and Reagents for Cryopreservation, by Region, 2021-2029
• Figure 16 : Global Market for CGT Tools and Reagents for Cell Expansion, by Region, 2021-2029
• Figure 17 : Global Market for CGT Tools and Reagents for Media, by Region, 2021-2029
• Figure 18 : Global Market for CGT Tools and Reagents for GMP Proteins, by Region, 2021-2029
• Figure 19 : Global Market for CGT Tools and Reagents for GMP Small Molecules, by Region, 2021-2029
• Figure 20 : Global Market for CGT Tools and Reagents for CRS Monitoring, by Region, 2021-2029
• Figure 21 : Global Market Shares of CGT Tools and Reagents, by Application, 2024
• Figure 22 : Global Market for CGT Tools and Reagents for Cancer, by Region, 2021-2029
• Figure 23 : Global Market for CGT Tools and Reagents for Rare Diseases, by Region, 2021-2029
• Figure 24 : Global Market for CGT Tools and Reagents for Other Diseases, by Region, 2021-2029
• Figure 25 : Global Market Shares of CGT Tools and Reagents, by End User, 2024
• Figure 26 : Global Market for CGT Tools and Reagents for Pharmaceutical and Biotech Firms, by Region, 2021-2029
• Figure 27 : Global Market for CGT Tools and Reagents for Academic Research Institutes, by Region, 2021-2029
• Figure 28 : Global Market for CGT Tools and Reagents for Clinical Labs, by Region, 2021-2029
• Figure 29 : Global Market Shares of CGT Tools and Reagents, by Region, 2024
• Figure 30 : North American Market for CGT Tools and Reagents, by Product, 2021-2029
• Figure 31 : North American Market for CGT Tools and Reagents, by Application, 2021-2029
• Figure 32 : North American Market for CGT Tools and Reagents, by End User, 2021-2029
• Figure 33 : European Market for CGT Tools and Reagents, by Product, 2021-2029
• Figure 34 : European Market for CGT Tools and Reagents, by Application, 2021-2029
• Figure 35 : European Market for CGT Tools and Reagents, by End User, 2021-2029
• Figure 36 : Asia-Pacific Market for CGT Tools and Reagents, by Product, 2021-2029
• Figure 37 : Asia-Pacific Market for CGT Tools and Reagents, by Application, 2021-2029
• Figure 38 : Asia-Pacific Market for CGT Tools and Reagents, by End User, 2021-2029
• Figure 39 : RoW Market for CGT Tools and Reagents, by Product, 2021-2029
• Figure 40 : RoW Market for CGT Tools and Reagents, by Application, 2021-2029
• Figure 41 : RoW Market for CGT Tools and Reagents, by End User, 2021-2029
• Figure 42 : How a Strong ESG Proposition Benefits Businesses
• Figure 43 : Global Market for Cell Therapy Biomanufacturing, by Product Type, 2021-2029
• Figure 44 : Global Market for Cell Therapy Biomanufacturing, by Application, 2021-2029
• Figure 45 : Market Dynamics of Cell Therapy Biomanufacturing
• Figure 46 : Global Market Shares of Cell Therapy Biomanufacturing, by Product Type, 2023
• Figure 47 : Global Market Shares of Cell Therapy Biomanufacturing, by Application, 2023
• Figure 48 : Global Market Shares of Cell Therapy Biomanufacturing, by Region, 2023
• Figure 49 : North American Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
• Figure 50 : European Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
• Figure 51 : Asia-Pacific Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
• Figure 52 : RoW Market Shares of Cell Therapy Biomanufacturing, by Country, 2023
• Figure 53 : Global Market for Gene Synthesis, by Services, 2020-2028
• Figure 54 : Market Dynamics of Gene Synthesis
• Figure 55 : Global Market Shares for Gene Synthesis, by Method, 2022
• Figure 56 : Global Market Shares for Gene Synthesis, by Services, 2022
• Figure 57 : Global Market Shares for Gene Synthesis, by Application, 2022
• Figure 58 : Global Market Shares for Gene Synthesis, by End User, 2022
• Figure 59 : Global Market Shares of Automated and Closed Cell Therapy, by Region, 2023
• Figure 60 : Market Dynamics of Global Automated and Closed Cell Therapy Market
• Figure 61 : Global Market Shares of Automated and Closed Cell Therapy, by Automation Type, 2023
• Figure 62 : Global Market for Semi-Automated Cell Therapy, by Region, 2021-2029
• Figure 63 : Global Market for Fully Automated Cell Therapy, by Region, 2021-2029
• Figure 64 : Global Market Shares of Automated and Closed Cell Therapy, by Cell Type, 2023
• Figure 65 : Global Market for Automated and Closed CAR-T Cell Therapy, 2021-2029
• Figure 66 : Global Market for Automated and Closed CAR-T Cell Therapy, by Region, 2021-2029
• Figure 67 : Global Market for Automated and Closed Stem Cell Therapy, 2021-2029
• Figure 68 : Global Market for Automated and Closed Stem Cell Therapy, by Region, 2021-2029
• Figure 69 : Global Market for Automated and Closed Other Cell Therapies, 2021-2029
• Figure 70 : Global Market for Automated and Closed Other Cell Therapies, by Region, 2021-2029
• Figure 71 : Global Market Shares of Automated and Closed Cell Therapy, by Application, 2023
• Figure 72 : Global Market for Clinical Automated and Closed Cell Therapy, 2021-2029
• Figure 73 : Global Market for Commercial Automated and Closed Cell Therapy, 2021-2029
• Figure 74 : Global Market Shares of Automated and Closed Cell Therapy, by Region, 2023
• Figure 75 : Global Market for Automated and Closed Cell Therapy, by Region, 2021-2029
• Figure 76 : North American Market Shares of Automated and Closed Cell Therapy, by Country, 2023
• Figure 77 : U.S. Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 78 : Canadian Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 79 : Mexican Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 80 : European Market Shares of Automated and Closed Cell Therapy, by Country, 2023
• Figure 81 : German Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 82 : French Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 83 : Italian Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 84 : Spanish Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 85 : U.K. Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 86 : Rest of European Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 87 : Asia-Pacific Market Shares of Automated and Closed Cell Therapy, by Country, 2023
• Figure 88 : Chinese Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 89 : Japanese Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 90 : Indian Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 91 : Australian Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 92 : South Korean Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 93 : Rest of Asia-Pacific Market for Automated and Closed Cell Therapy, 2021-2029
• Figure 94 : Global Market for Cell and Gene Therapy, by Type of Therapy, 2020-2028
• Figure 95 : Cell and Gene Therapy Market Dynamics
• Figure 96 : Global Market for Cell and Gene Therapy, by Type of Therapy, 2020-2028
• Figure 97 : Global Market Shares of Cell and Gene Therapy, by Type of Therapy, 2022
• Figure 98 : Global Market for Cell Therapy, by Region, 2020-2028
• Figure 99 : Global Market for Gene-modified Cell Therapy, by Region, 2020-2028
• Figure 100 : Global Market for Gene Therapy, by Region, 2020-2028
• Figure 101 : Global Market for Gene-modified Cell Therapy and Gene Therapy, by Vector Type, 2020-2028
• Figure 102 : Global Market Shares of Gene-modified Cell Therapy and Gene Therapy, by Vector Type, 2022
• Figure 103 : Global Market for AAV Vectors for Gene-modified Cell Therapy and Gene Therapy, 2020-2028
• Figure 104 : Global Market for Retroviral Vectors for Gene-modified Cell Therapy and Gene Therapy, 2020-2028
• Figure 105 : Global Market for Lentiviral Vectors for Gene-modified Cell Therapy and Gene Therapy, 2020-2028
• Figure 106 : Global Market for Other Vectors Used in Gene-modified Cell Therapy and Gene Therapy, 2020-2028
• Figure 107 : Global Market for Cell and Gene Therapy, by Drug Product, 2020-2028
• Figure 108 : Global Market Shares of Cell and Gene Therapy, by Drug Product, 2022
• Figure 109 : Global Market for Zolgensma for Cell and Gene Therapy, 2020-2028
• Figure 110 : Global Market for Yescarta for Cell and Gene Therapy, 2020-2028
• Figure 111 : Global Market for Kymriah for Cell and Gene Therapy, 2020-2028
• Figure 112 : Global Market for Abecma for Cell and Gene Therapy, 2020-2028
• Figure 113 : Global Market for Maci for Cell and Gene Therapy, 2020-2028
• Figure 114 : Global Market for Tecartus for Cell and Gene Therapy, 2020-2028
• Figure 115 : Global Market for Epicel for Cell and Gene Therapy, 2020-2028
• Figure 116 : Global Market for Other Types of Drugs Used in Drugs Cell and Gene Therapy, 2020-2028
• Figure 117 : Global Market for Cell and Gene Therapy, by Application, 2020-2028
• Figure 118 : Global Market Shares of Cell and Gene Therapy, by Application, 2022
• Figure 119 : Global Market Cell and Gene Therapy for Oncology, by Region, 2020-2028
• Figure 120 : Global Market for Cell and Gene Therapy for Rare Diseases, by Region, 2020-2028
• Figure 121 : Global Market for Cell and Gene Therapy for Ophthalmology, by Region, 2020-2028
• Figure 122 : Global Market for Cell and Gene Therapy for Other Therapeutic Areas, by Region, 2020-2028
• Figure 123 : Global Market for Cell and Gene Therapy, by Region, 2020-2028
• Figure 124 : Global Market Shares of Cell and Gene Therapy, by Region, 2022
• Figure 125 : North American Market Shares of Cell and Gene Therapy, by Country, 2022
• Figure 126 : U.S. Market for Cell and Gene Therapy, 2020-2028
• Figure 127 : Canadian Market for Cell and Gene Therapy, 2020-2028
• Figure 128 : Mexican Market for Cell and Gene Therapy, 2020-2028
• Figure 129 : European Market Shares of Cell and Gene Therapy, by Country, 2022
• Figure 130 : German Market for Cell and Gene Therapy, 2020-2028
• Figure 131 : U.K. Market for Cell and Gene Therapy, 2020-2028
• Figure 132 : French Market for Cell and Gene Therapy, 2020-2028
• Figure 133 : Rest of European Market for Cell and Gene Therapy, 2020-2028
• Figure 134 : Asia-Pacific Market Shares of Cell and Gene Therapy, by Country, 2022
• Figure 135 : Japanese Market for Cell and Gene Therapy, 2020-2028
• Figure 136 : Chinese Market for Cell and Gene Therapy, 2020-2028
• Figure 137 : Australian Market for Cell and Gene Therapy, 2020-2028
• Figure 138 : Rest of Asia-Pacific Market for Cell and Gene Therapy, 2020-2028
• Figure 139 : RoW Market for Cell and Gene Therapy, 2020-2028
• Figure 140 : Global Market for Live Cell Imaging, by Region, 2021-2029
• Figure 141 : Market Dynamics of Global Live Cell Imaging Market
• Figure 142 : Total Stem Cell Research Funding by the National Institutes for Health, 2013-2025
• Figure 143 : Global Market Shares of Live Cell Imaging, by Components, 2023
• Figure 144 : Global Market Shares of Live Cell Imaging, by Technology, 2023
• Figure 145 : Global Market Shares of Live Cell Imaging, by End-user, 2023
• Figure 146 : Global Market Shares of Live Cell Imaging, by Region, 2023
• Figure 147 : North American Market Shares of Live Cell Imaging, by Country, 2023
• Figure 148 : North American Market for Live Cell Imaging, by Components, 2021-2029
• Figure 149 : North American Market for Live Cell Imaging, by Technology, 2021-2029
• Figure 150 : North American Market for Live Cell Imaging, by End User, 2021-2029
• Figure 151 : U.S. Market for Live Cell Imaging, 2021-2029
• Figure 152 : Canadian Market for Live Cell Imaging, 2021-2029
• Figure 153 : Mexican Market for Live Cell Imaging, 2021-2029
• Figure 154 : European Market Shares of Live Cell Imaging, by Country, 2023
• Figure 155 : European Market for Live Cell Imaging, by Components, 2021-2029
• Figure 156 : European Market for Live Cell Imaging, by Technology, 2021-2029
• Figure 157 : European Market for Live Cell Imaging, by End User, 2021-2029
• Figure 158 : German Market for Live Cell Imaging, 2021-2029
• Figure 159 : U.K. Market for Live Cell Imaging, 2021-2029
• Figure 160 : French Market for Live Cell Imaging, 2021-2029
• Figure 161 : Spanish Market for Live Cell Imaging, 2021-2029
• Figure 162 : Italian Market for Live Cell Imaging, 2021-2029
• Figure 163 : Rest of European Market for Live Cell Imaging, 2021-2029
• Figure 164 : Asia-Pacific Market Shares of Live Cell Imaging, by Country, 2023
• Figure 165 : Asia-Pacific Market for Live Cell Imaging, by Components, 2021-2029
• Figure 166 : Asia-Pacific Market for Live Cell Imaging, by Technology, 2021-2029
• Figure 167 : Asia-Pacific Market for Live Cell Imaging, by End User, 2021-2029
• Figure 168 : Chinese Market for Live Cell Imaging, 2021-2029
• Figure 169 : Japanese Market for Live Cell Imaging, 2021-2029
• Figure 170 : Indian Market for Live Cell Imaging, 2021-2029
• Figure 171 : South Korean Market for Live Cell Imaging, 2021-2029
• Figure 172 : Rest of Asia-Pacific Market for Live Cell Imaging, 2021-2029
• Figure 173 : Rest of the World Market for Live Cell Imaging, by Components, 2021-2029
• Figure 174 : Rest of the World Market for Live Cell Imaging, by Technology, 2021-2029
• Figure 175 : Rest of the World Market for Live Cell Imaging, by End User, 2021-2029
• Figure 176 : Global Market for Single-Cell Technologies, by Product, 2021-2029
• Figure 177 : Market Dynamics of Single-Cell Technologies
• Figure 178 : Estimated Numbers of All Cancer Cases, Males and Females (0 to 85+ Years), 2022-2050
• Figure 179 : Personalized Medicine: Growing Share in Total New Molecular Entities (NMEs), 2019-2022
• Figure 180 : Percentage of Deaths from NCDs in Asia-Pacific Countries, 2019
• Figure 181 : Global Market Shares of Single-Cell Technologies, by Product, 2023
• Figure 182 : Global Market Shares of Single-Cell Technologies, by Cell Type, 2023
• Figure 183 : Global Market Shares of Single-Cell Technologies, by Technique, 2023
• Figure 184 : Cost for Sequencing a Human Genome, November 2017-May 2022
• Figure 185 : Global Market Shares of Single-Cell Technologies, by Application, 2023
• Figure 186 : Global Market Shares of Single-Cell Technologies, by End User, 2023
• Figure 187 : Examples of Research and Academic Laboratories Utilizing Single-Cell Technologies
• Figure 188 : Global Market Shares of Single-Cell Technologies, by Region, 2023
• Figure 189 : U.S. NIH Funding for Genome Research, 2021-2023
• Figure 190 : North American Market for Single-Cell Technologies, 2021-2029
• Figure 191 : European Market for Single-Cell Technologies, 2021-2029
• Figure 192 : Asia-Pacific Market for Single-Cell Technologies, 2021-2029
• Figure 193 : Rest of the World Market for Single-Cell Technologies, 2021-2029